相关实验视频
Updated: Sep 14, 2025

12:03
Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
28.1K
使用多式成像评估急性心肌梗塞的COVID-19:一个病例报告
Jingyao Wang1, Yachao Li1, Mengjie Lei1
1Department of Cardiology, Langfang People's Hospital, Hebei Medical University, Langfang Core Laboratory of Precision Treatment of CAD, Langfang, China.
Medicine
|July 23, 2025
概括
冠状病毒疾病2019 (COVID-19) 可能通过引起炎症和高凝血性,破坏冠状动脉斑块的稳定,引发急性心肌梗塞. 对COVID-19患者和心血管风险患者来说,监测炎症标志物至关重要.
科学领域:
- 心脏病学 心脏病学
- 传染性疾病 传染性疾病
- 血管生物学 血管生物学
背景情况:
- 心血管并发症,包括急性心肌梗塞,尽管2019年冠状病毒疾病 (COVID-19) 的全球影响减少,但仍然是令人担忧的.
- COVID-19可能会通过系统性炎症和高凝固性来破坏先前存在的冠状动脉斑块的稳定.
研究的目的:
- 调查COVID-19在急性心肌梗塞发展中的潜在作用.
- 为患有COVID-19后心血管事件的患者提供对诊断和治疗策略的见解.
主要方法:
- 一个41岁妇女的案例研究,在COVID-19诊断5天后,没有先前的心血管风险因素出现胸痛.
- 诊断程序包括心电图,托波I测量,紧急冠状动脉血管图和光学连贯性断层扫描.
- 干预措施包括血栓吸收,光学连贯性断层扫描引导的血管整形术,以及降脂和双抗血小板治疗的启动.
主要成果:
- 冠状动脉扫描显示了急性前心肌梗塞,这是由于90%的狭窄和左前下降动脉中的血栓.
- 光学连贯断层扫描发现了脆弱的,不破裂的斑块与巨细胞和胆固醇晶体.
- 术后成像显示残留斑块负担和心肌损伤,表明双重缺血和炎症过程.
结论:
- 由于COVID-19可能通过炎症和高凝固性促进动脉样硬化斑块的不稳定,从而诱导急性心肌梗塞.
- 监测炎症标志物和考虑抗炎治疗对于管理这些患者至关重要.
相关概念视频
Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Acute Coronary Syndrome I: Introduction
80
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
80
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
47
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
47
Imaging Studies for Cardiovascular System V: CT
66
Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
66
Myocarditis II: Clinical Features and Diagnostic Tests
24
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
24
Acute Coronary Syndrome IV: Interprofessional Care
30
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
30

